Noven Therapeutics recalls
FDA enforcement reports naming Noven Therapeutics, LLC as the recalling firm.
- Recall reports
- 7
- Class I (serious)
- 0
- Most recent report
- Apr 29, 2020
- Apr 29, 2020Daytrana (methylphenidate transdermal system) Delivers 10 mg over 9 hours (1Drug · Noven Therapeutics, LLCDefective Delivery System: Out of specification for mechanical peel and shear.Class II
- Apr 29, 2020Daytrana (methylphenidate transdermal system) Delivers 20 mg over 9 hours (2Drug · Noven Therapeutics, LLCDefective Delivery System: Out of specification for mechanical peel and shear.Class II
- Apr 29, 2020Daytrana (methylphenidate transdermal system) Delivers 30 mg over 9 hours (3Drug · Noven Therapeutics, LLCDefective Delivery System: Out of specification for mechanical peel and shear.Class II
- Mar 25, 2020Daytrana (methylphenidate transdermal system) patches, Delivers 10 mg over 9 hours (1Drug · Noven Therapeutics, LLCDefective Delivery System: Out of specification for mechanical peel and shear.Class II
- Mar 25, 2020Daytrana (methylphenidate transdermal system) patches, Delivers 20 mg over 9 hours (2Drug · Noven Therapeutics, LLCDefective Delivery System: Out of specification for mechanical peel and shear.Class II
- Mar 25, 2020Daytrana (methylphenidate transdermal system) patches, Delivers 15 mg over 9 hours (1Drug · Noven Therapeutics, LLCDefective Delivery System: Out of specification for mechanical peel and shear.Class II
- Mar 25, 2020Daytrana (methylphenidate transdermal system) patches, Delivers 30 mg over 9 hours (3Drug · Noven Therapeutics, LLCDefective Delivery System: Out of specification for mechanical peel and shear.Class II